Gilead Sciences, Inc.

13F Holdings History for Arcus Biosciences, Inc. - Common Stock, par value $0.0001 per share (RCUS)

Symbol: RCUS on NYSE
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Ownership: 31.4M shares
Security Ownership: 25.6%

Shares, Excluding Options vs Price

Value, Excluding Options

GILEAD SCIENCES, INC. ownership in Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share (RCUS)

2025-11-05 - GILEAD SCIENCES, INC. has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 31.4M shares of Arcus Biosciences, Inc. Common Stock, par value $0.0001 per share (RCUS). This represents 25.6% percent ownership of the company.

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filed at
GILEAD SCIENCES, INC.	25.6%	-13.7%	$427M	31.4M			$13.60	13D/A	11/3/2025	5 Nov 2025 17:19:42
GILEAD SCIENCES, INC.	29.7%	-15.1%	$255M	31.4M	-8,266,889	-20.8%	$8.12	13D/A	7/13/2025	15 Jul 2025 19:46:41
GILEAD SCIENCES, INC.	35%		$298M	39.7M			$7.50	13D/A	2/18/2025	5 Mar 2025 17:00:40
GILEAD SCIENCES, INC.	35%		$298M	39.7M			$7.50	13D/A	2/18/2025	20 Feb 2025 19:43:01

Holdings date	Weight	Change	Value $	Shares	Change	Price	All Holders
9/30/2025	23.9%		$427M	31.4M		$13.60	Q3 2025
6/30/2025	20%		$256M	31.4M		$8.14	Q2 2025
3/31/2025	20.9%	+0.91%	$247M	31.4M	+1,363,636	$7.85	Q1 2025
12/31/2024	28.9%		$448M	30.1M		$14.89	Q4 2024

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.